EBITDA margins declined 10 bps QoQ to 13.8% (vs. our estimate 14.6%) mainly on account of higher other expenses (up 9.1% QoQ) Reported PAT rose 5.7% QoQ to | 98.1 crore mainly on the back of lower tax rate (11.4% as percentage of PBT vs. 14.4% in Q2FY19) In-sourcing by top client, payer ramp down to impact FY19E topline Rupee revenues grew 3.2% QoQ but were below our expectations. This was mainly due to continuous headwinds in healthcare payer business impacting top 2-5 client growth (declined 5.7% QoQ). Further, revenue...